N6AMT1 rs995014: Understanding the Variant and Eye Health
The rs995014 variant is a single nucleotide polymorphism located within the N6AMT1 gene. Recent research has identified a suggestive statistical association between this variant and the risk of retinal vein occlusion in East Asian populations.
What each genotype means
Typical risk profile
This genotype represents the most common form of the N6AMT1 variant observed in many populations. Current research suggests this version is not associated with the increased risk of retinal vein occlusion identified in recent East Asian studies. As this association is based on limited evidence, individuals should focus on standard eye health practices and consult an ophthalmologist for routine screenings.
This is the most frequent genotype found across most global populations.
Potential risk association
This genotype includes one copy of the variant linked to retinal vein occlusion in recent East Asian genome-wide association studies. The clinical significance of carrying a single copy remains uncertain due to the limited nature of current research. You should discuss any concerns regarding eye health or vision changes with your healthcare provider.
This genotype is considered rare in most populations, with higher prevalence observed in specific East Asian cohorts.
Increased risk association
This genotype carries two copies of the variant that has been associated with a higher risk of retinal vein occlusion in recent East Asian studies. Because the evidence for this association is currently limited, it is not a diagnostic indicator of disease. Please maintain regular eye examinations and discuss this genetic finding with your clinician to determine if additional monitoring is appropriate for your health profile.
This genotype is rare, occurring infrequently in the general population and primarily documented in East Asian ancestry groups.
What is rs995014?
The identifier rs995014 refers to a specific single nucleotide polymorphism (SNP) in the human genome. SNPs are the most common type of genetic variation, representing a difference in a single DNA building block, or nucleotide. This particular variant is situated within the N6AMT1 gene region. In the context of genetic research, scientists study these variations to determine if they correlate with specific health traits or conditions. It is important to note that the presence of a SNP does not necessarily mean it causes a disease; rather, it may serve as a marker that is statistically linked to a trait. Because rs995014 is located in a non-coding region of the genome, its exact functional role in biological processes remains a subject of ongoing investigation.
The Role of N6AMT1
The N6AMT1 gene, also known as N6-adenine-specific DNA methyltransferase 1, encodes a protein that plays a role in cellular methylation processes. Methylation is a biochemical modification that can influence how genes are expressed without changing the underlying DNA sequence. While the primary functions of N6AMT1 are studied in the context of cellular metabolism and DNA repair, its connection to ocular health is a newer area of exploration. Researchers are currently working to understand how variations in or near this gene might influence the complex biological pathways that maintain the health of the retina. Because the retina is a highly specialized tissue, even subtle changes in gene regulation could theoretically impact its vascular integrity, though more functional studies are required to confirm these mechanisms.
Research and Evidence Strength
The association between rs995014 and retinal vein occlusion (RVO) has been highlighted in recent genome-wide association studies (GWAS) focusing on East Asian cohorts. In these studies, researchers scan the entire genome to find statistical correlations between specific variants and a condition. The evidence for rs995014 is currently classified as limited, meaning that while a statistical signal was observed, it has not yet been definitively proven to have a direct causal effect on RVO. Retinal vein occlusion is a condition where a vein in the retina becomes blocked, potentially leading to vision loss or blurriness. Because these findings are based on population-level statistics, they describe trends rather than individual outcomes. Further replication in diverse populations and functional validation in laboratory settings are necessary to fully understand the clinical significance of this variant.
Population Frequency
The rs995014 variant is considered rare in the general population. Genetic variants that are rare often show significant differences in frequency across various ancestral groups. The current evidence linking this SNP to retinal vein occlusion is primarily derived from East Asian cohorts, such as those studied in recent Taiwanese research. Because genetic architecture varies significantly between populations, it is not yet clear if this association holds true for individuals of European, African, or other ancestries. The rarity of the variant means that large-scale studies are required to gather enough data to draw robust conclusions about its distribution and its potential impact on health across different global populations.
Interpreting Genetic Information
When encountering information about genetic variants like rs995014, it is essential to maintain a balanced perspective. Genetic associations are statistical tools used by researchers to identify potential areas for further study; they are not diagnostic tools for individuals. If you are concerned about your eye health or have a family history of retinal conditions, the most appropriate step is to consult with an ophthalmologist or a medical professional. They can provide personalized assessments based on your clinical history, symptoms, and physical examinations. You cannot use a single SNP result to predict your personal risk of developing a condition like retinal vein occlusion. Always rely on professional medical advice rather than interpreting genetic data in isolation, as health is influenced by a complex interplay of genetics, environment, and lifestyle factors.
How common is this variant?
The rs995014 variant is documented as rare, with its frequency and associated research findings primarily observed in East Asian populations.
Frequently asked questions
Does having the rs995014 variant mean I will get retinal vein occlusion?
No. A genetic association is a statistical observation in a population, not a medical diagnosis. Many factors, including age, blood pressure, and overall health, play a much larger role in eye health than a single genetic variant.
Where can I get tested for this variant?
While some direct-to-consumer genetic tests may include this SNP, it is not a standard clinical test. Genetic testing for eye conditions should be discussed with a medical professional or a genetic counselor who can explain the relevance of the results.
What should I do if I am worried about my vision?
If you are experiencing blurry vision or any changes in your sight, you should schedule an appointment with an eye care professional, such as an optometrist or ophthalmologist. They can perform a comprehensive eye exam to assess your health regardless of your genetic profile.
Is this variant linked to other eye diseases?
Current research has specifically highlighted an association with retinal vein occlusion in East Asian cohorts. There is no established evidence linking this specific variant to other common eye diseases at this time.
Sources & further reading
Educational information only, last refreshed 10/10/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs995014?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29